Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent inhibitor of protein kinases. It inhibits MAPKs, which DUSP24 dephosphorylates. Inhibition of MAPKs results in reduced substrate availability for DUSP24, thereby decreasing its functional activity. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a specific inhibitor of MEK1/2, enzymes upstream in the MAPK/ERK pathway. Since DUSP24 is involved in dephosphorylating ERK, U0126 indirectly reduces DUSP24 activity by preventing ERK phosphorylation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of JNK, which is another MAPK regulated by DUSP24. By inhibiting JNK phosphorylation, SP600125 indirectly lowers the activity of DUSP24 by reducing its available substrates. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 specifically inhibits p38 MAPK. DUSP24 is known to dephosphorylate p38 MAPK; hence, inhibiting p38 MAPK phosphorylation indirectly reduces the functional activity of DUSP24. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. PI3K/Akt pathway activation can lead to phosphorylation of MAPKs, which are substrates for DUSP24. Inhibition of PI3K thus indirectly reduces DUSP24's activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 selectively inhibits MEK, which is involved in the activation of ERK, a substrate for DUSP24. By inhibiting MEK, PD98059 indirectly decreases the action of DUSP24. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, similar to LY294002. It decreases the phosphorylation of Akt and subsequent MAPK activation, leading to reduced substrate availability for DUSP24. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, which can affect MAPK signaling. As DUSP24 is a MAPK phosphatase, rapamycin indirectly reduces the potential substrates for DUSP24, thus inhibiting its function. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
Sorafenib is a kinase inhibitor that targets several enzymes including RAF, which is an upstream regulator of the MAPK pathway. By inhibiting RAF, Sorafenib reduces DUSP24's activity. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an Src family kinase inhibitor. Src can influence the MAPK pathway, and thus, by inhibiting Src, PP2 indirectly reduces the activity of DUSP24 by limiting its substrate availability. | ||||||